non-small cell lung cancer(non-squamous cell cancer)
Conditions
Interventions
None listed
Sponsors
National Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Non-squamous non-small cell lung cancer Pathological stage IA2 and high risk, or stage IA3, IB, IIA Entire lesion diameter 5cm or less Complete resection by lobectomy or segmentectomy EGFR gene mutation has been confirmed Postoperative adjuvant therapy with tegafur/uracil or osimertinib, or observation without treatment is planned. 18 years or older ECOG performance status 0-1 Written consent has been obtained from the patient
Exclusion criteria
Exclusion criteria: Cases that fall under any of the following items will be excluded. 1) Have active multiple cancers*1 2) Have a local or systemic active infection that requires treatment 3) Pregnant women, lactating women, and women who may be currently pregnant. 4) Registration in this study is judged to be difficult due to a clinically problematic mental illness. 5) Receiving continuous systemic administration of steroids or immunosuppressants 6) Have a history of severe hypersensitivity 7) Exclusion provisions regarding complications (a) Have a history of ILD, drug-induced ILD, radiation pneumonitis requiring steroid treatment, or have active ILD. (b) Viral hepatitis HBs antigen positive or HCV antibody positive (c) HIV positive (however, negative confirmation by serum test is not required). 8) Other cases deemed inappropriate by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival | — |
Countries
Japan
Contacts
Public ContactTomohiro Miyoshi
National Cancer Center Hospital East Division of Thoracic Surgery
Outcome results
None listed